Importantly, data on tumor mass and mouse survival both indicate that Bap1 knockout tumors exhibited an unresponsive status to immune checkpoint blockade therapy, such as anti-PD1 antibody (Fig. 1H-I). The gene discussed is BAP1; the disease is neoplasm.